Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 RA, helps people ...

Eli Lilly reports Phase 3 data showing oral obesity drug orforglipron maintained weight loss after Wegovy or Zepbound, beating placebo.

Obesity is not a single disease. New research shows distinct biological phenotypes that explain why weight gain and treatment ...

When we think of weight-loss strategies, logging plenty of exercise is often top of mind. But what if working out isn’t an ...

Many factors affect the speed at which a person loses weight, including weight loss method, age, genetics, and more. Aim for gradual weight loss of 1 to 2 pounds per week, or 5% to 10% body weight ...

Research suggests certain medications could help build or maintain muscle during weight loss. Here's how they work & how to ...

According to Lilly, a New Drug Application for orforglipron for the treatment of adults with obesity or overweight has been submitted to the Food and Drug Administration.

Maintaining a healthy weight is a ubiquitous challenge, often marked by a persistent struggle despite earnest efforts to diet and exercise. For many individuals, achieving their desired weight or ...

New research reveals that taking a GLP-1 can be equivalent to '10 years of ageing' on the body, if proper precautions aren't ...

You can lose weight on semaglutide without exercise. Focus on good nutrition, sleep, and stress management to maximize weight ...

To maintain your weight, you may need to consume the same amount of calories you burn. It can help to use an online calculator or learn the equation to determine the amount. Your metabolism and the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with obesity and type 2 diabetes had a mean 14 kg ...